GLP-1 Medications and PCOS: Weight, Insulin Resistance, Cycles and Pregnancy Planning

Women with polycystic ovary syndrome often tell me the same frustrating story: they eat carefully, they exercise, and the scale barely moves while cravings stay loud. That experience isn’t a lack of willpower. PCOS is closely tied to insulin resistance, which makes weight harder to lose and easier to regain.

GLP-1 medications such as semaglutide and tirzepatide have drawn a lot of interest from women with PCOS. Below I’ll cover how PCOS and metabolism connect, what the research suggests, and the precautions — especially around pregnancy — that I discuss with every patient.

PCOS is a metabolic condition, not only a reproductive one

PCOS is diagnosed based on a combination of irregular or absent ovulation, signs of higher androgens (such as acne or excess hair growth, or elevated levels on blood tests), and polycystic-appearing ovaries on ultrasound. Beyond those features, many women with PCOS have insulin resistance, whatever their weight.

Higher insulin levels can prompt the ovaries to make more androgens, which disrupts ovulation. It’s a cycle: insulin resistance worsens PCOS symptoms, and PCOS raises the risk of prediabetes, type 2 diabetes, high cholesterol and fatty liver. That’s why the international evidence-based PCOS guideline emphasizes lifestyle and metabolic care alongside reproductive treatment.

What GLP-1 medications may offer

GLP-1 medications are not FDA-approved specifically for PCOS. They are approved for type 2 diabetes and, in eligible adults, for chronic weight management. When a woman with PCOS also meets weight-management criteria, these medications can be a reasonable option.

Research in women with PCOS, mostly smaller studies, has suggested that GLP-1 medications can help with:

• Weight loss, often more than with lifestyle changes or metformin alone.
• Insulin sensitivity and blood sugar markers.
• Menstrual regularity in some women, likely related to weight loss and lower insulin.
• Androgen levels, with modest reductions reported in some studies.

Even a 5 to 10 percent weight loss can improve ovulation and metabolic health in PCOS. The 2023 international guideline acknowledges GLP-1 medications as an option for weight management in adults with PCOS, alongside lifestyle care.

The pregnancy precaution everyone should hear

This is the part I stress most. As insulin resistance improves and weight comes down, ovulation can return — sometimes quickly, and sometimes in women who had been told they might struggle to conceive. Unplanned pregnancies do happen.

• GLP-1 medications are not recommended during pregnancy.
• Semaglutide labeling advises stopping at least two months before a planned pregnancy because the drug stays in the body for weeks.
• Tirzepatide may reduce the effectiveness of oral birth control pills, particularly after starting and after each dose increase. Its labeling recommends switching to a non-oral method or adding a barrier method during those periods.

If you are trying to conceive, the plan should be coordinated with your gynecologist or fertility specialist. If you are not, reliable contraception needs to be part of the conversation from day one.

Who should be cautious

GLP-1 medications are not appropriate for anyone with a personal or family history of medullary thyroid cancer or MEN2, and they call for caution with a history of pancreatitis or gallbladder disease. Women with PCOS have higher rates of disordered eating than the general population, and I screen for that carefully before prescribing appetite-suppressing medication.

It’s also worth ruling out other causes of irregular cycles — thyroid disease, elevated prolactin and others — with appropriate lab work before assuming everything is PCOS.

A complete plan for PCOS

Medication works best as one part of care:

1. Nutrition built around adequate protein and fiber, which also helps with GI side effects.
2. Strength training to protect muscle and improve insulin sensitivity.
3. Sleep assessment — sleep apnea is more common in PCOS.
4. Attention to skin concerns. Acne and unwanted hair can affect quality of life, and laser hair removal is one option for hair growth once hormones are addressed.

Frequently asked questions

Are GLP-1 medications approved for PCOS?

No. They are approved for type 2 diabetes and chronic weight management. Women with PCOS who meet those criteria may be candidates.

Can a GLP-1 medication make my periods regular?

Some women see more regular cycles as weight and insulin levels improve, but it isn’t guaranteed.

Can I take a GLP-1 while trying to get pregnant?

No. These medications should be stopped before trying to conceive; semaglutide labeling advises at least two months beforehand.

Can I use it with metformin?

Sometimes the two are used together. Your prescriber should decide based on your history and labs.

Let’s build your plan together

If PCOS has made weight management feel impossible, a complimentary, no-commitment consultation is a good first step. Our medical weight loss program is supervised by trained medical professionals under my oversight.

• Hudson, OH: 50 W Streetsboro St, Suite 2 · (330) 460-5915
• Barboursville, WV: 1 Chateau Grove Ln · (304) 520-0461

Ask about Easy Pay financing.

References: Teede HJ, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Journal of Clinical Endocrinology and Metabolism. 2023. · Semaglutide injection prescribing information. U.S. FDA labeling. · Tirzepatide injection prescribing information. U.S. FDA labeling.

This article is for general information only and is not medical advice. Treatments are provided only after consultation and evaluation by a licensed provider. Individual results vary.